Mostrar el registro sencillo del ítem

dc.contributor.authorMasia, Mar
dc.contributor.authorPadilla, Sergio
dc.contributor.authorMoreno, Santiago
dc.contributor.authorBarber, Xavier
dc.contributor.authorIribarren, Jose A
dc.contributor.author
dc.contributor.authorGomez-Sirvent, Juan L
dc.contributor.authorRivero, Maria
dc.contributor.authorVidal, Francesc
dc.contributor.authorCampins Rosselló, Antoni
dc.contributor.authorGutierrez, Felix
dc.contributor.authorCohorte Red Invest Sida CoRIS
dc.date.accessioned2024-07-11T09:10:43Z
dc.date.available2024-07-11T09:10:43Z
dc.date.issued2017-09-08
dc.identifier.citationMasia M, Padilla S, Moreno S, Barber X, Iribarren JA, Del Romero J, et al. Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach. PLoS One. 2017 Sep 08;12(9):e0184329.en
dc.identifier.issn1932-6203
dc.identifier.otherhttp://hdl.handle.net/20.500.13003/9650
dc.identifier.urihttp://hdl.handle.net/20.500.12105/20455
dc.description.abstractObjetives Outcomes of people living with HIV (PLWH) developing non-AIDS events (NAEs) remain poorly defined. We aimed to classify NAEs according to severity, and to describe clinical outcomes and prognostic factors after NAE occurrence using data from CoRIS, a large Spanish HIV cohort from 2004 to 2013. Design Prospective multicenter cohort study. Methods Using a multistate approach we estimated 3 transition probabilities: from alive and NAE-free to alive and NAE-experienced (NAE development); from alive and NAE-experienced to death (Death after NAE);and from alive and NAE-free to death (Death without NAE). We analyzed the effect of different covariates, including demographic, immunologic and virologic data, on death or NAE development, based on estimates of hazard ratios (HR). We focused on the transition Death after NAE. Results 8,789 PLWH were followed-up until death, cohort censoring or loss to follow-up. 792 first incident NAEs occurred in 9.01% PLWH (incidence rate 28.76; 95% confidence interval [CI], 26.80-30.84, per 1000 patient-years). 112 (14.14%) NAE-experienced PLWH and 240 (2.73%) NAE-free PLWH died. Adjusted HR for the transition Death after NAE was 12.1 (95% CI, 4.90-29.89). There was a graded increase in the adjusted HRs for mortality according to NAE severity category: HR (95% CI), 4.02 (2.45-6.57) for intermediate-severity; and 9.85 (5.45-17.81) for serious NAEs compared to low-severity NAEs. Male sex (HR 2.04; 95% CI, 1.11-3.84), age> 50 years (1.78, 1.08-2.94), hepatitis C-coinfection (2.52, 1.38-4.61), lower CD4 cell count at cohort entry (HR 2.49; 95% CI 1.20-5.14 for CD4 cell count below 200 and HR 2.16; 95% CI 1.01-4.66 for CD4 cell count between 200-350, both compared to CD4 cell count higher than 500) and concomitant CD4< 200 cells/mL (2.22, 1.42-3.44) were associated with death after NAE. CD4 count and HIV-1 RNA at engagement, previous AIDS and hepatitis C-coinfection predicted mortality in NAE-free persons. Conclusion NAEs, including low-severity events, increase prominently the risk for mortality in PLWH. Prognostic factors differ between NAE-experienced and NAE-free persons. These findings should be taken into account in the clinical management of PLWH developing NAEs and may permit more targeted prevention efforts.en
dc.description.sponsorshipThis work was supported by the RD12/0017/0023 and RD 16/0025/0038 projects as part of the Plan Nacional R + D + I and cofinanced by ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER), FIS (PI08/893), FIS (PI13/02256), FIS (PI16/01740), FISABIO UGP-14-197, Contrato de Intensificacion de la Actividad Investigadora INT 14/00207, Contrato Predoctotal FISABIO 2015 (UGP-15-152) and Contrato Rio Hortega (CM15/00187).es_ES
dc.language.isoengen
dc.publisherPublic Library of Science (PLOS) en
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.meshMortality *
dc.subject.meshPrognosis *
dc.subject.meshViral Load *
dc.subject.meshCD4 Lymphocyte Count *
dc.subject.meshHIV Infections *
dc.subject.meshMale *
dc.subject.meshSpain *
dc.subject.meshFemale *
dc.subject.meshHumans *
dc.subject.meshCause of Death *
dc.subject.meshComorbidity *
dc.subject.meshIncidence *
dc.titlePrediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approachen
dc.typeresearch articleen
dc.rights.licenseAttribution 4.0 International*
dc.identifier.pubmedID28886092es_ES
dc.format.volume12es_ES
dc.format.number9es_ES
dc.format.pagee0184329es_ES
dc.identifier.doi10.1371/journal.pone.0184329
dc.relation.publisherversionhttps://dx.doi.org/10.1371/journal.pone.0184329en
dc.identifier.journalPloS Onees_ES
dc.rights.accessRightsopen accessen
dc.subject.decsIncidencia*
dc.subject.decsComorbilidad*
dc.subject.decsHumanos*
dc.subject.decsCausas de Muerte*
dc.subject.decsPronóstico*
dc.subject.decsRecuento de Linfocito CD4*
dc.subject.decsFemenino*
dc.subject.decsInfecciones por VIH*
dc.subject.decsMortalidad*
dc.subject.decsEspaña*
dc.subject.decsMasculino*
dc.subject.decsCarga Viral*
dc.identifier.scopus2-s2.0-85029487713
dc.identifier.wos410001100097
dc.identifier.puiL618237772


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution 4.0 International
Este Item está sujeto a una licencia Creative Commons: Attribution 4.0 International